Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585299 · ClinicalTrials.gov registry record · NA
Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00585299 is a NA study that has completed, run by Yale University. The registered enrollment target is 4 participants.
The verdict
NCT00585299, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To assess whether reversal of fatty liver by moderate weight loss (8% of body weight) will lead to improvements in insulin sensitivity, which will be associated with changes in both glucose status and lipid profiles, in obese children and adolescents with fatty liver who have normal glucose or pre-diabetes.
Interventions
- OTHER Low-fat diet
- OTHER Traditional diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585299
The ClinicalTrials.gov registry entry for NCT00585299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low-fat diet is the first listed.
NCT00585299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00585299 about?
NCT00585299 is a clinical study titled "Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD". To assess whether reversal of fatty liver by moderate weight loss (8% of body weight) will lead to improvements in insulin sensitivity, which will be associated with changes in both glucose status and lipid profiles, in obese children and adolescents with fatty liver who have normal glucose or pre-d...
What is the current status of trial NCT00585299?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2006-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00585299?
The interventions under investigation include: Low-fat diet (OTHER), Traditional diet (OTHER).
Who is sponsoring clinical trial NCT00585299?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.